Form 4: Cardlytics Director Scott A. Hill Acquires 11,000 Restricted Stock Units

Director Scott A. Hill acquired 11,000 restricted stock units in Cardlytics, Inc. on May 23, 2024.

Summary

• On May 23, 2024, Scott A. Hill, a director of Cardlytics, Inc., acquired 11,000 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of Cardlytics common stock or its cash equivalent, at the issuer's election.
• The RSUs will vest in full on the one-year anniversary of the grant date, provided Hill remains a director on that date.
• Following the transaction, Hill directly owns 11,000 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing indicating a director's acquisition of stock units, which can be seen as a positive sign of confidence, but it's not overwhelmingly positive.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The RSUs will vest in full on the one-year anniversary of the grant date, provided that the Reporting Person remains a director of the Issuer on such vesting date.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company insiders, such as directors, and their confidence in the company's prospects.

Stakeholder Impact

• The acquisition of RSUs by a director can positively influence shareholder sentiment.

Key Dates